- BNF:
- 5.1.13
- Status:
- Green
- Decision Date:
- None
Comments
First line for UTI
The modified release preparation is a cost
effective option.
If used
long term for prophylaxis:
- monitor full blood count, renal function and
liver function tests every 6 months
- advise patients of the risk of pulmonary and hepatic fibrosis, peripheral and
optic neuropathy, and to report symptoms if they develop during
treatment.
See MHRA April 2023 - Nitrofurantoin: reminder of the risks of pulmonary and hepatic adverse drug reactions
search again